GLP1R and Sepsis: Supporting a function of GLP-1 in modulating immune responses, circulating GLP-1 was reported to be increased in states of chronic inflammatory disease, including the metabolic syndrome, coronary artery disease, or heart failure (58–60) but also in critically ill patients and patients with sepsis (61).